Report Code: A10358 | Mar 2021 | Pages: 206 | ||
Tables: 91 | Charts: 39 |
|
Pandemic disrupted the entire world and affected many industries.
Get detailed COVID-19 impact analysis on the Wearable Patch Market
Request Now !The global wearable patch market size was valued at $12,239.7 million in 2019, and is projected to reach $27,820.5 million by 2027, registering a CAGR of 9.6% from 2020 to 2027.
Wearable patch, also known as smart patch or electronic skin, is used for disease monitoring, drug delivery, and diagnosis. Wearable patches help to maintain health and wellbeing in elderly patients suffering from chronic conditions such as diabetes and cardiovascular diseases.
Rise in technological advancements in wearable patches, increase in prevalence of chronic diseases, and growth in awareness among consumers regarding wearable patches are the major factors that propel the market growth. In addition, rise in technological advancements in wearable patches also drive the market growth. Features such as continuous monitoring of patients, coupled with precise data, minimal interference with body movements, and easier connectivity with smartphones assist the wearable patch market growth. For instance, Koninklijke Philips N.V. received the United States Food and Drug Administration (USFDA) approval for Philips Biosensor BX100, a disposable wearable sensor patch in May 2020, which can track heart rate and respiratory rate, once a patient is discharged from intensive care unit.
Connected wearables are portable in nature, feature wireless connectivity, and are mostly used to monitor heart rate via Bluetooth. It also uses microprocessor controller and myoelectric technology. Moreover, these patches are compatible with most mobile operating systems and can be connected easily through Bluetooth. Connected wearable patches collect data at regular intervals and transmit it to connected devices such as smartphones and laptops. They eliminate the need for physical consultation with doctors by remotely monitoring health of patients.
However, high cost of sensor patches and concerns regarding data privacy and security hamper the wearable patch market growth. For instance, average price of electrocardiogram sensor patch is between $ 300 and $ 4,500.
Global Wearable Patch Market Segmentation
The wearable patch market is categorized into product, end use, and region. On the basis of product, the market is segmented into temperature patch, blood glucose patch, blood pressure patch, heart rate patch & ECG patch, skin care patch, and others. The blood glucose patch measures glucose levels in the interstitial fluid between the cells under the skin. The blood glucose patch segment led the market in 2019, and is expected to continue this trend throughout the forecast period, as several patients with diabetes are advised to monitor blood glucose on a regular basis to prevent development of hyperglycemia or hypoglycemia and to facilitate control over diabetes.
Â
By end use, the global wearable patch medical market is segregated into healthcare and fitness and sports. The fitness and sports segment is expected to witness considerable market growth during the forecast period, owing to gradual increase in use of wearable patches by athletes to gain health data insights to support their performance. For instance, Abbott Laboratories’ Libre Sense Glucose Sport Biosensor is designed for sports use and provides streaming glucose data with a dynamic range of 55-200 mg/dL for performance athletes to monitor their glucose levels. Biosensors are designed to provide glucose monitoring experience that enable athletes understand efficacy of their nutrition choices during training and competition. It informs athletes to take nutrition appropriately, to fill their glycogen stores prior to a race and to know when to replenish during a race in order to maintain athletic performance.
Region wise, the wearable patch market is analyzed across North America, Europe, Asia-Pacific, and LAMEA. The market in Asia-Pacific is expected to register the fastest CAGR during the forecast period pertaining to presence of large population base, increase in awareness regarding wearable patches, and rise in disposable income. Increase in need to provide cost-effective and quality clinical care to patients propels implementation and integration of medical devices and healthcare IT solutions in this region, which creates opportunities for existing companies and new market entrants.
The wearable patch market is highly competitive in nature, as major players in this vertical are concentrating on growth strategies such as product launches, mergers and acquisitions (M&As), partnerships and collaborations to gain competitive advantage. For instance, in June 2020, in the U.S., Abbott laboratories received an approval from the USFDA for its FreeStyle Libre 2 integrated continuous glucose monitoring (iCGM) system for adults and children aged above 4 suffering from diabetes.
The key players operating in the global wearable patch market include Abbott Laboratories, iRhythm Technologies, Inc., Johnson & Johnson Services, Inc., Koninklijke Philips N.V., L’Oreal Group, LifeSignals, Inc., Medtronic Plc (Zephyr Technology Corporation), Qualcomm Technologies, Inc., VitalConnect, Inc., and VivaLNK.Â
Key Benefits For Stakeholders
Wearable Patch Market Report Highlights
Aspects | Details |
---|---|
By Product |
|
By End Use |
|
By Region |
|
Key Market Players | Koninklijke Philips N.V., VivaLNK, LifeSignals, Inc., L’Oreal Group, Abbott Laboratories, Johnson & Johnson Services, Inc., Medtronic plc (Zephyr Technology Corporation), Qualcomm Technologies, Inc., iRhythm Technologies, Inc., VitalConnect , Inc. |
CHAPTER 1:INTRODUCTION
1.1.Report description
1.2.Key benefits for stakeholders
1.3.Key market segments
1.4.Research methodology
1.4.1.Secondary research
1.4.2.Primary research
1.4.3.Analyst tools and models
CHAPTER 2:EXECUTIVE SUMMARY
2.1.Key findings of the study
2.2.CXO perspective
CHAPTER 3:MARKET LANDSCAPE
3.1.Market definition and scope
3.2.Key findings
3.2.1.Top investment pockets
3.2.2.Top winning strategies
3.3.Porter’s five forces analysis
3.4.Top player positioning, 2019
3.5.Market dynamics
3.5.1.Drivers
3.5.1.1.Increasing technological advancements in wearable patch
3.5.1.2.Growing awareness among consumers regarding wearable patch
3.5.1.3.Rising prevalence of chronic diseases
3.5.1.4.Increased demand for the connected wearable patches
3.5.2.Restraints
3.5.2.1.High cost of sensor patch
3.5.2.2.Concerns regarding data privacy and security
3.5.3.Opportunity
3.5.3.1.Increase in adoption of telehealth
3.5.4.Impact analysis
3.6.Impact analysis of COVID-19 on wearable patch market
CHAPTER 4:WEARABLE PATCH MARKET, BY PRODUCT
4.1.Overview
4.1.1.Market size and forecast
4.2.Temperature patch
4.2.1.Market size and forecast, by region
4.2.2.Market analysis, by country
4.3.Blood glucose patch
4.3.1.Market size and forecast, by region
4.3.2.Market analysis, by country
4.4.Blood pressure patch
4.4.1.Market size and forecast, by region
4.4.2.Market analysis, by country
4.5.Heart rate patch & ECG patch
4.5.1.Market size and forecast, by region
4.5.2.Market analysis, by country
4.6.Skin care patch
4.6.1.Market size and forecast, by region
4.6.2.Market analysis, by country
4.7.Others
4.7.1.Market size and forecast, by region
4.7.2.Market analysis, by country
CHAPTER 5:WEARABLE PATCH MARKET, BY END USE
5.1.Overview
5.1.1.Market size and forecast
5.2.Healthcare
5.2.1.Market size and forecast, by region
5.2.2.Market analysis, by country
5.3.Fitness and sports
5.3.1.Market size and forecast, by region
5.3.2.Market analysis, by country
CHAPTER 6:WEARABLE PATCH MARKET, BY REGION
6.1.Overview
6.1.1.Market size and forecast
6.2.North America
6.2.1.North America market size and forecast, by product
6.2.2.North America market size and forecast, by end use
6.2.3.North America market size and forecast, by country
6.2.4.U.S.
6.2.4.1.U.S. market size and forecast, by product
6.2.4.2.U.S. market size and forecast, by end use
6.2.5.Canada
6.2.5.1.Canada market size and forecast, by product
6.2.5.2.Canada market size and forecast, by end use
6.2.6.Mexico
6.2.6.1.Mexico market size and forecast, by product
6.2.6.2.Mexico market size and forecast, by end use
6.3.Europe
6.3.1.Europe market size and forecast, by product
6.3.2.Europe market size and forecast, by end use
6.3.3.Europe market size and forecast, by country
6.3.4.Germany
6.3.4.1.Germany market size and forecast, by product
6.3.4.2.Germany market size and forecast, by end use
6.3.5.France
6.3.5.1.France market size and forecast, by product
6.3.5.2.France market size and forecast, by end use
6.3.6.UK
6.3.6.1.UK market size and forecast, by product
6.3.6.2.UK market size and forecast, by end use
6.3.7.Italy
6.3.7.1.Italy market size and forecast, by product
6.3.7.2.Italy market size and forecast, by end use
6.3.8.Spain
6.3.8.1.Spain market size and forecast, by product
6.3.8.2.Spain market size and forecast, by end use
6.3.9.Rest of Europe
6.3.9.1.Rest of Europe market size and forecast, by product
6.3.9.2.Rest of Europe market size and forecast, by end use
6.4.Asia-Pacific
6.4.1.Asia-Pacific market size and forecast, by product
6.4.2.Asia-Pacific market size and forecast, by end use
6.4.3.Asia-Pacific market size and forecast, by country
6.4.4.Japan
6.4.4.1.Japan market size and forecast, by product
6.4.4.2.Japan market size and forecast, by end use
6.4.5.China
6.4.5.1.China market size and forecast, by product
6.4.5.2.China market size and forecast, by end use
6.4.6.Australia
6.4.6.1.Australia market size and forecast, by product
6.4.6.2.Australia market size and forecast, by end use
6.4.7.India
6.4.7.1.India market size and forecast, by product
6.4.7.2.India market size and forecast, by end use
6.4.8.South Korea
6.4.8.1.South Korea market size and forecast, by product
6.4.8.2.South Korea market size and forecast, by end use
6.4.9.Rest of Asia-Pacific
6.4.9.1.Rest of Asia-Pacific market size and forecast, by product
6.4.9.2.Rest of Asia-Pacific market size and forecast, by end use
6.5.LAMEA
6.5.1.LAMEA market size and forecast, by product
6.5.2.LAMEA market size and forecast, by end use
6.5.3.LAMEA market size and forecast, by country
6.5.4.Brazil
6.5.4.1.Brazil market size and forecast, by product
6.5.4.2.Brazil market size and forecast, by end use
6.5.5.Saudi Arabia
6.5.5.1.Saudi Arabia market size and forecast, by product
6.5.5.2.Saudi Arabia market size and forecast, by end use
6.5.6.South Africa
6.5.6.1.South Africa market size and forecast, by product
6.5.6.2.South Africa market size and forecast, by end use
6.5.7.Rest of LAMEA
6.5.7.1.Rest of LAMEA market size and forecast, by product
6.5.7.2.Rest of LAMEA market size and forecast, by end use
CHAPTER 7:COMPANY PROFILES
7.1.Abbott Laboratories
7.1.1.Company overview
7.1.2.Company snapshot
7.1.3.Operating business segments
7.1.4.Product portfolio
7.1.5.Business performance
7.1.6.Key strategic moves and developments
7.2.iRhythm Technologies, Inc.
7.2.1.Company overview
7.2.2.Company snapshot
7.2.3.Operating business segments
7.2.4.Product portfolio
7.2.5.Business performance
7.2.6.Key strategic moves and developments
7.3.Johnson & Johnson Services, Inc.
7.3.1.Company overview
7.3.2.Company snapshot
7.3.3.Operating business segments
7.3.4.Product portfolio
7.3.5.Business performance
7.3.6.Key strategic moves and developments
7.4.Koninklijke Philips N.V.
7.4.1.Company overview
7.4.2.Company snapshot
7.4.3.Operating business segments
7.4.4.Product portfolio
7.4.5.Business performance
7.4.6.Key strategic moves and developments
7.5.L’Oreal Group
7.5.1.Company overview
7.5.2.Company snapshot
7.5.3.Operating business segments
7.5.4.Product portfolio
7.5.5.Business performance
7.5.6.Key strategic moves and developments
7.6.LifeSignals, Inc.
7.6.1.Company overview
7.6.2.Company snapshot
7.6.3.Operating business segments
7.6.4.Product portfolio
7.6.5.Key strategic moves and developments
7.7.Medtronic plc (Zephyr Technology Corporation)
7.7.1.Company overview
7.7.2.Company snapshot
7.7.3.Operating business segments
7.7.4.Product portfolio
7.7.5.Business performance
7.8.Qualcomm Technologies, Inc.
7.8.1.Company overview
7.8.2.Company snapshot
7.8.3.Operating business segments
7.8.4.Product portfolio
7.8.5.Business performance
7.9.VitalConnect , Inc.
7.9.1.Company overview
7.9.2.Company snapshot
7.9.3.Operating business segments
7.9.4.Product portfolio
7.9.5.Key strategic moves and developments
7.10.VivaLNK
7.10.1.Company overview
7.10.2.Company snapshot
7.10.3.Operating business segments
7.10.4.Product portfolio
7.10.5.Key strategic moves and developments
LIST OF TABLES
TABLE 01.GLOBAL WEARABLE PATCH MARKET, BY PRODUCT, 2019–2027 ($MILLION)
TABLE 02.GLOBAL WEARABLE PATCH MARKET FOR TEMPERATURE PATCH, BY REGION, 2019–2027 ($MILLION)
TABLE 03.GLOBAL WEARABLE PATCH MARKET FOR BLOOD GLUCOSE PATCH, BY REGION, 2019–2027 ($MILLION)
TABLE 04.GLOBAL WEARABLE PATCH MARKET FOR BLOOD PRESSURE PATCH, BY REGION, 2019–2027 ($MILLION)
TABLE 05.GLOBAL WEARABLE PATCH MARKET FOR HEART RATE PATCH & ECG PATCH, BY REGION, 2019–2027 ($MILLION)
TABLE 06.GLOBAL WEARABLE PATCH MARKET FOR SKIN CARE PATCH, BY REGION, 2019–2027 ($MILLION)
TABLE 07.GLOBAL WEARABLE PATCH MARKET FOR OTHERS, BY REGION, 2019–2027 ($MILLION)
TABLE 08.GLOBAL WEARABLE PATCH MARKET, BY END USE, 2019–2027 ($MILLION)
TABLE 09.GLOBAL WEARABLE PATCH MARKET FOR HEALTHCARE, BY REGION, 2019–2027 ($MILLION)
TABLE 10.GLOBAL WEARABLE PATCH MARKET FOR FITNESS AND SPORTS, BY REGION, 2019–2027 ($MILLION)
TABLE 11.WEARABLE PATCH MARKET, BY REGION, 2019–2027, ($MILLION)85
TABLE 12.NORTH AMERICA WEARABLE PATCH MARKET, BY PRODUCT, 2019–2027, ($MILLION)
TABLE 13.NORTH AMERICA WEARABLE PATCH MARKET, BY END USE, 2019–2027, ($MILLION)
TABLE 14.NORTH AMERICA WEARABLE PATCH MARKET, BY COUNTRY, 2019–2027, ($MILLION)
TABLE 15.U.S. WEARABLE PATCH MARKET, BY PRODUCT, 2019–2027, ($MILLION)
TABLE 16.U.S. WEARABLE PATCH MARKET, BY END USE, 2019-2027, ($MILLION)
TABLE 17.CANADA WEARABLE PATCH MARKET, BY PRODUCT, 2019–2027, ($MILLION)
TABLE 18.CANADA WEARABLE PATCH MARKET, BY END USE, 2019-2027, ($MILLION)
TABLE 19.MEXICO WEARABLE PATCH MARKET, BY PRODUCT, 2019–2027, ($MILLION)
TABLE 20.MEXICO WEARABLE PATCH MARKET, BY END USE, 2019-2027, ($MILLION)
TABLE 21.EUROPE WEARABLE PATCH MARKET, BY PRODUCT, 2019–2027, ($MILLION)
TABLE 22.EUROPE WEARABLE PATCH MARKET, BY END USE, 2019–2027, ($MILLION)
TABLE 23.EUROPE WEARABLE PATCH MARKET, BY COUNTRY, 2019–2027, ($MILLION)
TABLE 24.GERMANY WEARABLE PATCH MARKET, BY PRODUCT, 2019–2027, ($MILLION)
TABLE 25.GERMANY WEARABLE PATCH MARKET, BY END USE, 2019-2027, ($MILLION)
TABLE 26.FRANCE WEARABLE PATCH MARKET, BY PRODUCT, 2019–2027, ($MILLION)
TABLE 27.FRANCE WEARABLE PATCH MARKET, BY END USE, 2019-2027, ($MILLION)
TABLE 28.UK WEARABLE PATCH MARKET, BY PRODUCT, 2019–2027, ($MILLION)
TABLE 29.UK WEARABLE PATCH MARKET, BY END USE, 2019-2027, ($MILLION)
TABLE 30.ITALY WEARABLE PATCH MARKET, BY PRODUCT, 2019–2027, ($MILLION)
TABLE 31.ITALY WEARABLE PATCH MARKET, BY END USE, 2019-2027, ($MILLION)
TABLE 32.SPAIN WEARABLE PATCH MARKET, BY PRODUCT, 2019–2027, ($MILLION)
TABLE 33.SPAIN WEARABLE PATCH MARKET, BY END USE, 2019-2027, ($MILLION)
TABLE 34.REST OF EUROPE WEARABLE PATCH MARKET, BY PRODUCT, 2019–2027, ($MILLION)
TABLE 35.REST OF EUROPE WEARABLE PATCH MARKET, BY END USE, 2019-2027, ($MILLION)
TABLE 36.ASIA-PACIFIC WEARABLE PATCH MARKET, BY PRODUCT, 2019–2027, ($MILLION)
TABLE 37.ASIA-PACIFIC WEARABLE PATCH MARKET, BY END USE, 2019–2027, ($MILLION)
TABLE 38.ASIA-PACIFIC WEARABLE PATCH MARKET, BY COUNTRY, 2019–2027, ($MILLION)
TABLE 39.JAPAN WEARABLE PATCH MARKET, BY PRODUCT, 2019–2027, ($MILLION)
TABLE 40.JAPAN WEARABLE PATCH MARKET, BY END USE, 2019-2027, ($MILLION)
TABLE 41.CHINA WEARABLE PATCH MARKET, BY PRODUCT, 2019–2027, ($MILLION)
TABLE 42.CHINA WEARABLE PATCH MARKET, BY END USE, 2019-2027, ($MILLION)
TABLE 43.AUSTRALIA WEARABLE PATCH MARKET, BY PRODUCT, 2019–2027, ($MILLION)
TABLE 44.AUSTRALIA WEARABLE PATCH MARKET, BY END USE, 2019-2027, ($MILLION)
TABLE 45.INDIA WEARABLE PATCH MARKET, BY PRODUCT, 2019–2027, ($MILLION)
TABLE 46.INDIA WEARABLE PATCH MARKET, BY END USE, 2019-2027, ($MILLION)
TABLE 47.SOUTH KOREA WEARABLE PATCH MARKET, BY PRODUCT, 2019–2027, ($MILLION)
TABLE 48.SOUTH KOREA WEARABLE PATCH MARKET, BY END USE, 2019-2027, ($MILLION)
TABLE 49.REST OF ASIA-PACIFIC WEARABLE PATCH MARKET, BY PRODUCT, 2019–2027, ($MILLION)
TABLE 50.REST OF ASIA-PACIFIC WEARABLE PATCH MARKET, BY END USE, 2019-2027, ($MILLION)
TABLE 51.LAMEA WEARABLE PATCH MARKET, BY PRODUCT, 2019–2027, ($MILLION)
TABLE 52.LAMEA WEARABLE PATCH MARKET, BY END USE, 2019–2027, ($MILLION)
TABLE 53.LAMEA WEARABLE PATCH MARKET, BY COUNTRY, 2019–2027, ($MILLION)
TABLE 54.BRAZIL WEARABLE PATCH MARKET, BY PRODUCT, 2019–2027, ($MILLION)
TABLE 55.BRAZIL WEARABLE PATCH MARKET, BY END USE, 2019-2027, ($MILLION)
TABLE 56.SAUDI ARABIA WEARABLE PATCH MARKET, BY PRODUCT, 2019–2027, ($MILLION)
TABLE 57.SAUDI ARABIA WEARABLE PATCH MARKET, BY END USE, 2019-2027, ($MILLION)
TABLE 58.SOUTH AFRICA WEARABLE PATCH MARKET, BY PRODUCT, 2019–2027, ($MILLION)
TABLE 59.SOUTH AFRICA WEARABLE PATCH MARKET, BY END USE, 2019-2027, ($MILLION)
TABLE 60.REST OF LAMEA WEARABLE PATCH MARKET, BY PRODUCT, 2019–2027, ($MILLION)
TABLE 61.REST OF LAMEA WEARABLE PATCH MARKET, BY END USE, 2019-2027, ($MILLION)
TABLE 62.ABBOTT: COMPANY SNAPSHOT
TABLE 63.ABBOTT: OPERATING BUSINESS SEGMENTS
TABLE 64.ABBOTT: PRODUCT PORTFOLIO
TABLE 65.IRHYTHM: COMPANY SNAPSHOT
TABLE 66.IRHYTHM: OERATING SEGMENT
TABLE 67.IRHYTHM: PRODUCT PORTFOLIO
TABLE 68.J&J: COMPANY SNAPSHOT
TABLE 69.J&J: OPERATING BUSINESS SEGMENTS
TABLE 70.J&J: PRODUCT PORTFOLIO
TABLE 71.PHILIPS: COMPANY SNAPSHOT
TABLE 72.PHILIPS: OPERATING SEGMENTS
TABLE 73.PHILIPS: PRODUCT PORTFOLIO
TABLE 74.L’OREAL: COMPANY SNAPSHOT
TABLE 75.L’OREAL: OPERATING SEGMENTS
TABLE 76.L’OREAL: PRODUCT PORTFOLIO
TABLE 77.LIFESIGNALS: COMPANY SNAPSHOT
TABLE 78.LIFESIGNALS: OERATING SEGMENT
TABLE 79.LIFESIGNALS: PRODUCT PORTFOLIO
TABLE 80.MEDTRONIC: COMPANY SNAPSHOT
TABLE 81.MEDTRONIC: OPERATING SEGMENTS
TABLE 82.MEDTRONIC: PRODUCT PORTFOLIO
TABLE 83.QUALCOMM: COMPANY SNAPSHOT
TABLE 84.: OERATING SEGMENT
TABLE 85.QUALCOMM: PRODUCT PORTFOLIO
TABLE 86.VITALCONNECT: COMPANY SNAPSHOT
TABLE 87.VITALCONNECT: OERATING SEGMENT
TABLE 88.VITALCONNECT: PRODUCT PORTFOLIO
TABLE 89.VIVALNK: COMPANY SNAPSHOT
TABLE 90.VIVALNK: OERATING SEGMENT
TABLE 91.VIVALNK: PRODUCT PORTFOLIO
LIST OF FIGURES
FIGURE 01.GLOBAL WEARABLE PATCH MARKET SEGMENTATION
FIGURE 02.TOP INVESTMENT POCKETS
FIGURE 03.TOP WINNING STRATEGIES, BY YEAR, 2018–2020
FIGURE 04.TOP WINNING STRATEGIES, BY DEVELOPMENT, 2018–2020
FIGURE 05.TOP WINNING STRATEGIES, BY COMPANY, 2018–2020
FIGURE 06.LOW BARGAINING POWER OF SUPPLIERS
FIGURE 07.HIGH BARGAINING POWER OF BUYERS
FIGURE 08.HIGH THREAT OF SUBSTITUTES
FIGURE 09.MODERATE THREAT OF NEW ENTRANTS
FIGURE 10.MODERATE INTENSITY OF RIVALRY
FIGURE 11.TOP PLAYER POSITIONING, 2019
FIGURE 12.IMPACT ANALYSIS
FIGURE 13.COMPARATIVE ANALYSIS OF GLOBAL WEARABLE PATCH MARKET FOR TEMPERATURE PATCH, BY COUNTRY, 2019 & 2027 (%)
FIGURE 14.COMPARATIVE ANALYSIS OF GLOBAL WEARABLE PATCH MARKET FOR BLOOD GLUCOSE PATCH, BY COUNTRY, 2019 & 2027 (%)
FIGURE 15.COMPARATIVE ANALYSIS OF GLOBAL WEARABLE PATCH MARKET FOR BLOOD PRESSURE PATCH, BY COUNTRY, 2019 & 2027 (%)
FIGURE 16.COMPARATIVE ANALYSIS OF GLOBAL WEARABLE PATCH MARKET FOR HEART RATE PATCH & ECG PATCH, BY COUNTRY, 2019 & 2027 (%)
FIGURE 17.COMPARATIVE ANALYSIS OF GLOBAL WEARABLE PATCH MARKET FOR SKIN CARE PATCH, BY COUNTRY, 2019 & 2027 (%)
FIGURE 18.COMPARATIVE ANALYSIS OF GLOBAL WEARABLE PATCH MARKET FOR OTHERS, BY COUNTRY, 2019 & 2027 (%)
FIGURE 19.COMPARATIVE ANALYSIS OF GLOBAL WEARABLE PATCH MARKET FOR HEALTHCARE, BY COUNTRY, 2019 & 2027 (%)
FIGURE 20.COMPARATIVE ANALYSIS OF GLOBAL WEARABLE PATCH MARKET FOR FITNESS AND SPORTS, BY COUNTRY, 2019 & 2027 (%)
FIGURE 21.ABBOTT: NET SALES, 2017–2019 ($MILLION)
FIGURE 22.ABBOTT: REVENUE SHARE, BY SEGMENT, 2019 (%)
FIGURE 23.ABBOTT: REVENUE SHARE, BY REGION, 2019 (%)
FIGURE 24.IRHYTHM: NET SALES, 2017–2019 ($MILLION)
FIGURE 25.J&J: NET SALES, 2017–2019 ($MILLION)
FIGURE 26.J&J: REVENUE SHARE, BY SEGMENT, 2019 (%)
FIGURE 27.J&J: REVENUE SHARE, BY REGION, 2019 (%)
FIGURE 28.PHILIPS: NET SALES, 2017–2019 ($MILLION)
FIGURE 29.PHILIPS: REVENUE SHARE BY SEGMENT, 2019 (%)
FIGURE 30.PHILIPS: REVENUE SHARE BY REGION, 2019(%)
FIGURE 31.L’OREAL: NET SALES, 2017–2019 ($MILLION)
FIGURE 32.L’OREAL: REVENUE SHARE BY SEGMENT, 2019 (%)
FIGURE 33.L’OREAL: REVENUE SHARE BY REGION, 2019 (%)
FIGURE 34.MEDTRONIC: NET SALES, 2018–2020 ($MILLION)
FIGURE 35.MEDTRONIC: REVENUE SHARE BY SEGMENT, 2020 (%)
FIGURE 36.MEDTRONIC: REVENUE SHARE BY REGION, 2020 (%)
FIGURE 37.QUALCOMM: NET SALES, 2018–2020 ($MILLION)
FIGURE 38.QUALCOMM: REVENUE SHARE, BY SEGMENT, 2020 (%)
FIGURE 39.QUALCOMM: REVENUE SHARE, BY REGION, 2020 (%)
The wearable patch market is expected to witness profitable growth in the future. The market growth is characterized by factors such as technological advancements in wearable patches, rise in prevalence of chronic diseases, and growth in awareness among consumers regarding wearable patches. Moreover, the wearable patch market has gained immense interest in the healthcare industry over years as they are intended for diagnosis, treatment, or management of certain diseases.
As per the analysis in the report, the market in Asia-Pacific is projected to register highest growth rate, owing to presence of large population base, coupled with rise in prevalence of chronic diseases, growth in awareness about wearable patches, and rise in disposable income.
In addition, high cost of sensor patches and concerns regarding data privacy and security are anticipated to challenge growth of the market participants during the forecast period. Wearable devices are designed to collect user's health data, which can be analyzed to provide information about health status of users. Wearable devices contain huge user data, which puts security and privacy on risk. Moreover, it also may consist of sensitive information data, which may pose challenges such as data breach. Thus, these concerns regarding data privacy and security are anticipated to limit the market growth during the forecast period.
Â
A. Wearable patch, also called as smart patch or electronic skin, is used for disease monitoring and diagnosis applications.
A. Wearable patch help to maintain health and wellbeing in elderly patients suffering from chronic conditions such as diabetes and others.
A. The total value of wearable patch market was $12,239.7 million in 2019.
A. The market has drawn the interest of the healthcare industry, owing to increasing prevalence of chronic diseases, rise in technological advancements in wearable patch, and growing awareness among consumers regarding wearable patch
A. The forecast period in the report is from 2020-2027.
A. The market value of opthalmic devices market in 2027 was $27,820.5 million.
A. The base year calculated in the report is 2019.
A. Increased demand for the connected wearable patches will drive the market over the near future according to the KOLs.
A. By product, the blood glucose patch segment holds the maximum market share.
A. The market in Asia-Pacific is expected to register lucrative CAGR of 10.50% over the forecast period owing to presence of large population base, increase in awareness regarding wearable patches, and rise in disposable income
Start reading instantly.
This Report and over 67,404+ more Reports, Available with Avenue Library. T&C*.
Enterprise
License/PDF
Library
Membership
*Taxes/Fees, if applicable will be added during checkout. All prices in USD
To ensure high-level data integrity, accurate analysis, and impeccable forecasts
For complete satisfaction
On-demand customization of scope of the report to exactly meet your needs
Targeted market view to provide pertinent information and save time of readers
Get insights on topics that are crucial for your business. Stay abreast of your interest areas.
Get Industry Data AlertsTo ensure high-level data integrity, accurate analysis, and impeccable forecasts
For complete satisfaction
On-demand customization of scope of the report to exactly meet your needs
Targeted market view to provide pertinent information and save time of readers